Post date June 20, 2023 Experience Cadeler $597 million combination with Eneti We are advising Cadeler on the transaction
Post date May 17, 2023 Experience Forbion European Acquisition combination with enGene We are advising Forbion European Acquisition on its de-SPAC transaction
Post date May 12, 2023 Experience GSK exclusive licensing agreement with Scynexis We advised GSK on the transaction
Post date May 10, 2023 Experience Livent $10.6 billion merger of equals with Allkem We are advising Livent on the transaction
Post date May 3, 2023 Experience Cellular Biomedicine Group CAR-T collaboration and license agreement with Janssen We are advising Cellular Biomedicine Group on the transaction
Post date April 26, 2023 Experience Carrier Global €12 billion acquisition of Viessmann Climate Solutions We are advising Viessmann Group on the transaction
Post date April 12, 2023 Experience Emerson $8.2 billion acquisition of National Instruments We are advising Emerson on the transaction
Post date April 4, 2023 Experience Natura $2.525 billion sale of Aesop to L’Oréal We are advising Natura on the transaction
Post date March 24, 2023 Experience Japan Industrial Partners $15.2 billion acquisition of Toshiba We are advising Japan Industrial Partners on the acquisition
Post date March 19, 2023 Experience UBS $3.2 billion acquisition of Credit Suisse We are advising UBS on the transaction